How is aortic stenosis classified by etiology, severity, and symptom status?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Classification of Aortic Stenosis

Aortic stenosis should be classified using a three-dimensional framework: (1) by etiology (calcific tricuspid, bicuspid, or rheumatic), (2) by hemodynamic severity using a staging system (Stages A through D), and (3) by flow-gradient patterns that integrate valve area, gradient, ejection fraction, and stroke volume index. 1

Classification by Etiology

The anatomic cause determines natural history and age of presentation 2:

  • Calcific stenosis of tricuspid valve: Most common in elderly patients (>75 years), representing the predominant etiology in North America and Europe
  • Bicuspid aortic valve with calcification: More common in younger patients (<65 years), presents earlier due to abnormal hemodynamics accelerating calcification
  • Rheumatic valve disease: Rare in developed countries but still prevalent worldwide, typically involves mitral valve as well
  • Congenital unicuspid valve: Rare in adults, presents with severe dysmorphic features and often concurrent aortic regurgitation

Classification by Severity Staging

The 2020 ACC/AHA staging system provides a disease progression framework 1:

Stage A: At Risk

  • Patients with risk factors (bicuspid valve, sclerosis) but no hemodynamic obstruction
  • No intervention indicated; focus on risk factor modification

Stage B: Progressive AS

  • Mild-to-moderate hemodynamic obstruction
  • Valve velocity <4 m/s or mean gradient <40 mmHg
  • Asymptomatic with normal LV function
  • Requires periodic surveillance

Stage C: Asymptomatic Severe AS

Subdivided into:

  • C1: Severe AS (Vmax ≥4 m/s, mean gradient ≥40 mmHg, AVA ≤1.0 cm²) with normal LVEF
  • C2: Severe AS with LV systolic dysfunction (LVEF <50%)

Stage D: Symptomatic Severe AS

Critical for intervention decisions, subdivided by flow-gradient patterns:

  • D1: High-gradient severe AS (Vmax ≥4 m/s, mean gradient ≥40 mmHg, AVA ≤1.0 cm²)
  • D2: Low-flow, low-gradient AS with reduced LVEF (<50%) and stroke volume index <35 mL/m²
  • D3: Paradoxical low-flow, low-gradient AS with normal LVEF but low stroke volume index <35 mL/m²

Classification by Flow-Gradient Patterns

This advanced classification integrates multiple hemodynamic parameters 2:

High-Gradient Severe AS

  • Aortic Vmax ≥4 m/s or mean gradient ≥40 mmHg
  • AVA ≤1.0 cm² (or indexed AVA ≤0.6 cm²/m²)
  • Normal or high flow (SVi ≥35 mL/m²)
  • Most straightforward diagnosis with concordant parameters

Low-Flow, Low-Gradient AS with Reduced LVEF (Classic)

Defined by all four criteria 2:

  1. AVA <1.0 cm²
  2. Mean gradient <40 mmHg
  3. LVEF <50%
  4. Stroke volume index <35 mL/m²

Critical distinction: Use low-dose dobutamine stress echo to differentiate:

  • True severe AS: AVA remains ≤1.0 cm² at all flow rates, with Vmax ≥4 m/s or mean gradient ≥40 mmHg when flow increases
  • Pseudo-severe AS: AVA increases to >1.0 cm² with augmented flow
  • Contractile reserve: >20% increase in stroke volume predicts better surgical outcomes but does not exclude severe AS

Paradoxical Low-Flow, Low-Gradient AS with Preserved LVEF

Most challenging subgroup requiring careful verification 2:

  • AVA <1.0 cm² (ideally ≤0.8 cm²)
  • Mean gradient <40 mmHg (typically 30-40 mmHg)
  • LVEF ≥50%
  • SVi <35 mL/m² confirmed by alternative methods (3D TEE, CT, CMR)

Diagnostic criteria to confirm true severe AS 2:

  • Clinical: Elderly (>70 years), typical symptoms, physical exam consistent with severe AS
  • Qualitative imaging: LV hypertrophy, reduced longitudinal function
  • Quantitative: Aortic valve calcium score by CT (men ≥3000, women ≥1600 Agatston units indicates very likely severe AS; men <1600, women <800 suggests unlikely severe AS)

Normal-Flow, Low-Gradient AS

  • AVA <1.0 cm² but Vmax <4 m/s and mean gradient <40 mmHg
  • Normal LVEF and normal flow (SVi ≥35 mL/m²)
  • Critical pitfall: Most commonly represents measurement error rather than true severe AS
  • Requires meticulous verification of LVOT diameter measurement and exclusion of technical errors
  • If Vmax <3.0 m/s and mean gradient <20 mmHg, severe AS diagnosis should be questioned

Key Clinical Pitfalls

Measurement errors are the most common cause of discordant grading 2:

  • LVOT diameter measurement inaccuracy (1 mm error causes 10% change in calculated AVA)
  • Mistaking mitral regurgitation jet for AS jet (use timing: MR is longer, from mitral closure to opening)
  • Uncontrolled hypertension artificially elevating gradients
  • Concurrent significant mitral regurgitation or stenosis affecting flow calculations

Flow state assessment is essential 3, 4:

  • Low-flow states (SVi <35 mL/m²) occur in 21-28% of severe AS patients
  • Low-flow, low-gradient AS carries worse prognosis than high-gradient AS even with preserved LVEF
  • Always confirm low flow with alternative methods beyond standard Doppler when making critical decisions

Symptom status independently predicts outcomes 5, 6:

  • Symptomatic moderate AS has similar mortality risk to asymptomatic severe AS
  • Even NYHA Class II symptoms with moderate AS significantly increase mortality (HR 1.63)
  • Symptom assessment must be systematic and documented at each evaluation

This integrated classification system allows precise risk stratification and guides intervention timing, recognizing that AS severity exists on a continuum requiring synthesis of anatomic, hemodynamic, and clinical data rather than reliance on any single parameter.

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.